Abstract submissions for the 2025 Florida Society of Anesthesiologists Annual Meeting are now closed.
Abstract acceptance/rejection notifications went out on Tuesday, April 8, 2025. If you did not receive your acceptance/rejection notification, please check your spam/junk folder. If you still did not receive it, please email [email protected] and include your Abstract ID number as well as the title of your abstract.
NOTE: To facilitate a faster and smoother abstract submission and review process, ALL abstracts MUST be submitted online through our abstract submission site. It’s a web based abstract submissions site, which will allow you to submit abstracts formatted as have been done in the past. The site will also allow graphics, tables, charts and diagrams to be included in your abstract submission.
NOTE: ALL content authors are required to disclose ALL financial relationship(s) with an ACCME-defined commercial interest (‘industry’) in any dollar amount within the past 24 months. Also, no content author may be an owner or employee of a commercial interest.
2025 User Guide For The Submission Website
Please note the following submission rules and guidelines:
- Abstracts and all accompanying materials must be submitted online.
- The Abstract must represent original work that has not been published or presented prior to the dates of this meeting (abstracts presented at local/university research symposiums may be submitted).
- Abstracts will be reviewed and selected by members of the Abstract Review Committee.
- We consider the Presentations to be an educational activity, and therefore must be free of bias. All sources of support must be acknowledged through the disclosure section of the online submissions site.
- Generic names should be used versus brand names when possible. Also, the use of words such as novel, unique, robust, and excellent is thought to be promotional, and must be substantiated by proper references or p-values. When possible, use pharmacologic agent, medication, therapy, or a similar term, instead of drug.
- The Society reserves the right to edit your abstract for publication, and if done so, will send a copy for your approval following the scientific review.
- One of the authors of the Abstract must be present during the specified hours of the Session(s). Please indicate on this form which author will be presenting author.
- Presenters are responsible for all personal expenses (travel, hotel, etc.). Presenters must be registered for the Meeting on the day of the Session, and are responsible for the associated conference fees.
- Notice and Registration: Each abstract’s designated contact person will be notified (via email ONLY) of acceptance. Presenting author must register for the meeting.
- Poster Presentations: Accepted poster authors will be advised of set-up and take down schedule in their notice of acceptance.
- Abstracts are limited to 500 words
- Images and tables are allowed in the submission but images must be no larger than 1MB and must be no larger than 900 pixels high by 900 pixels wide.
Each abstract should be constructed as follows:
Introduction/Background
Methods
Results
Discussion/Conclusion
If you have any questions, please contact the FSA office:
Email: [email protected] • Phone: 786-300-3183 (ext. 118) • FAX: 310-437-0585